Statements (66)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:herpesviridae_family
|
| gptkbp:belongs_to |
gptkb:Herpesviridae
|
| gptkbp:burial_place |
skin lesions
|
| gptkbp:can_lead_to |
secondary bacterial infections
|
| gptkbp:caused_by |
chickenpox
shingles viral meningitis childhood rashes congenital varicella syndrome hospitalization in children fetal varicella syndrome |
| gptkbp:communication |
airborne droplets
direct contact with lesions |
| gptkbp:complications |
gptkb:healthcare_organization
gptkb:psychologist |
| gptkbp:conservation_status |
nerve cells
|
| gptkbp:difficulty |
immunocompromised individuals
|
| gptkbp:discovered_by |
gptkb:1954
|
| gptkbp:disease_resistance |
newborns
|
| gptkbp:focuses_on |
clinical research
public health campaigns infectious disease research |
| gptkbp:has_a |
gptkb:Varicella_vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Varicella-Zoster Virus
|
| gptkbp:includes |
MMR-V vaccine
|
| gptkbp:incubation_period |
all lesions crusted over
|
| gptkbp:is_associated_with |
postherpetic neuralgia
varicella pneumonia chickenpox vaccine efficacy |
| gptkbp:is_involved_in |
viral latency
|
| gptkbp:is_known_for |
gptkb:VZV
reactivate after stress |
| gptkbp:is_linked_to |
increased healthcare costs
increased risk of shingles chickenpox complications |
| gptkbp:is_monitored_by |
gptkb:CDC
|
| gptkbp:is_often_depicted_as |
gptkb:Person
|
| gptkbp:is_part_of |
herpesvirus family
human virome |
| gptkbp:is_protected_by |
vaccination
herd immunity |
| gptkbp:is_related_to |
gptkb:Epstein-Barr_virus
|
| gptkbp:is_studied_in |
virology
pathogenic mechanisms |
| gptkbp:is_vulnerable_to |
1-2 days before rash appears
|
| gptkbp:issues |
pregnant women
healthcare workers immunocompromised patients |
| gptkbp:members |
gptkb:alpha_herpesviruses
|
| gptkbp:recognizes |
PCR testing
|
| gptkbp:replaced_by |
vesicular fluid
|
| gptkbp:risk_factor |
gptkb:herpes_zoster
stroke in older adults |
| gptkbp:scientific_classification |
an enveloped virus
|
| gptkbp:seed_dispersal |
125 kb
|
| gptkbp:social_responsibility |
clinical symptoms
|
| gptkbp:subject |
epidemiological studies
public health surveillance vaccine safety studies |
| gptkbp:targets |
antiviral drug development
vaccine development |
| gptkbp:treatment |
gptkb:acyclovir
antiviral medications |
| gptkbp:type_of |
double-stranded DNA virus
|